Taunia Markvicka's Net Worth

$4.09 Million

Estimate Recalculated Nov 7, 2024 04:47PM EST

Who is Taunia Markvicka

Taunia Markvicka has an estimated net worth of $4.09 Million. This is based on reported shares across multiple companies, which include Pacira Pharmaceuticals, Inc., CorMedix Inc., and Statera Biopharma, Inc..

SEC CIK

Taunia Markvicka's CIK is 0001545282

Past Insider Trading and Trends

2013 was Taunia Markvicka's most active year for acquiring shares with 4 total transactions. Taunia Markvicka's most active month to acquire stocks was the month of January. 2013 was Taunia Markvicka's most active year for disposing of shares, totalling 11 transactions. Taunia Markvicka's most active month to dispose stocks was the month of October. 2013 saw Taunia Markvicka paying a total of $666,970.94 for 104,454 shares, this is the most they've acquired in one year. In 2013 Taunia Markvicka cashed out on 208,908 shares for a total of $4,523,007.81, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Pacira Pharmaceuticals, Inc.

SVP, Chief Commercial Officer
Updated Mar 19, 2015
Form 4
$5.49
$45.84K
Mar 19, 2015
8.81K
Options
Mar 17
Form 4
230.00
$86.62
$19.92K
Nov 12, 2014
230.00
Purchase
Nov 07
Form 4
70.00K
Jun 05, 2014
70.00K
Grant
Jun 03
Form 4
-33.33%
-50.00K
$30.98
-$2.02M
Nov 08, 2013
100.00K
Sale
ScheduledNov 06
Form 4
-54.50%
-10.00K
$26.25
-$415.10K
Sep 27, 2013
8.35K
Sale
ScheduledSep 25
Form 4
-68.74%
-14.70K
$19.31
-$520.23K
Aug 16, 2013
6.69K
Sale
ScheduledAug 14
Form 4
-100.00%
-29.75K
$16.81
-$904.22K
Jul 15, 2013
Sale
ScheduledJul 12
Form 4
150.00K
Jun 07, 2012
150.00K
Grant
Jun 05
Form 3
Mar 29, 2012
Showing 9 results

CorMedix Inc.

Investor
Updated May 17, 2017
Form 4
64.16%
14.50K
$0.51
$7.40K
May 17, 2017
260.67K
Purchase
May 15
Form 4
53.57K
Feb 23, 2017
246.17K
Grant
Feb 21
Form 4
465.00%
18.60K
$1.65
$30.69K
Aug 29, 2016
192.60K
Purchase
Aug 25
Form 4
90.00K
$1.91
$171.90K
Feb 24, 2016
174.00K
Grant
Feb 22
Form 4
4.00K
$4.81
$19.24K
Jun 25, 2015
84.00K
Purchase
Jun 23
Form 4
50.00K
$5.62
$281.00K
Mar 03, 2015
80.00K
Grant
Mar 02
Form 4
30.00K
Apr 08, 2014
30.00K
Grant
Apr 04
Form 3
Apr 08, 2014
Showing 8 results

Statera Biopharma, Inc.

Chief Operating Officer
Updated Sep 30, 2021
Form 4
100.00K
Sep 30, 2021
100.00K
Grant
Sep 28
Form 3
Jul 29, 2021
Showing 2 results